Literature DB >> 8132576

Association of peroxisome proliferator-activated receptor and Hsp72.

Q Huang1, K Alvares, R Chu, C A Bradfield, J K Reddy.   

Abstract

In an effort to understand the relationship between a 72-kDa heat shock protein (Hsp72) and peroxisome proliferator-activated receptors (PPARs), we have characterized their interaction using clofibric acid-Sepharose chromatography and co-immunoprecipitation with antisera raised against either rat PPAR (rPPAR) or Hsp72. First, we observed that both rPPAR and Hsp72 elute in a clofibrate-dependent manner from the clofibric acid-Sepharose matrix. Second, we found that immunoprecipitation of either protein from solution resulted in the precipitation of the other. This result was obtained from rat liver cytosol, from Spodoptera frugiperda (Sf9) insect cells expressing rPPAR, and from reticulocyte lysate rPPAR expression systems. These results suggest that Hsp72 and rPPAR form a complex in vivo and that Hsp72 may play a role in the folding, subcellular localization, and/or signaling pathway of PPARs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132576

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Corepressors of agonist-bound nuclear receptors.

Authors:  Igor Gurevich; Anthony M Flores; Brian J Aneskievich
Journal:  Toxicol Appl Pharmacol       Date:  2007-06-14       Impact factor: 4.219

2.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

3.  Dual role for Hsc70 in the biogenesis and regulation of the heme-regulated kinase of the alpha subunit of eukaryotic translation initiation factor 2.

Authors:  S Uma; V Thulasiraman; R L Matts
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Therapeutic Implications of PPARgamma in Human Osteosarcoma.

Authors:  Eric R Wagner; Bai-Cheng He; Liang Chen; Guo-Wei Zuo; Wenli Zhang; Qiong Shi; Qing Luo; Xiaoji Luo; Bo Liu; Jinyong Luo; Farbod Rastegar; Connie J He; Yawen Hu; Barrett Boody; Hue H Luu; Tong-Chuan He; Zhong-Liang Deng; Rex C Haydon
Journal:  PPAR Res       Date:  2010-02-16       Impact factor: 4.964

5.  Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.

Authors:  R Chu; L D Madison; Y Lin; P Kopp; M S Rao; J L Jameson; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Regulation of Proteome Maintenance Gene Expression by Activators of Peroxisome Proliferator-Activated Receptor α.

Authors:  Hongzu Ren; Beena Vallanat; Holly M Brown-Borg; Richard Currie; J Christopher Corton
Journal:  PPAR Res       Date:  2011-01-17       Impact factor: 4.964

7.  FGF21 Protects Against Hypoxia Injury Through Inducing HSP72 in Cerebral Microvascular Endothelial Cells.

Authors:  Hao-Wei Wang; Xin Jiang; Yu Zhang; Jian Wang; Jian Xie; Yong-Qiang Wang; Yong-Hua Li
Journal:  Front Pharmacol       Date:  2019-02-20       Impact factor: 5.810

8.  Analysis of the heat shock response in mouse liver reveals transcriptional dependence on the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).

Authors:  Beena Vallanat; Steven P Anderson; Holly M Brown-Borg; Hongzu Ren; Sander Kersten; Sudhakar Jonnalagadda; Rajagopalan Srinivasan; J Christopher Corton
Journal:  BMC Genomics       Date:  2010-01-07       Impact factor: 3.969

9.  NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.

Authors:  Yaru Li; Mingming Chen; Yu Zhou; Chuanfeng Tang; Wen Zhang; Ying Zhong; Yadong Chen; Hong Zhou; Liang Sheng
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.